Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Natech Plastics is a contract development and manufacturing company focused on medical devices, in vitro diagnostics, life sciences consumables, and selected pharmaceutical packaging applications. The company provides end-to-end services spanning design and engineering support, in-house moldmaking, custom injection molding, automation, assembly, filling and sealing, sterile packaging, and scale-up from prototype through commercial production. Natech emphasizes complex polymer-based consumables, microfluidic and cartridge-based products, and regulated manufacturing supported by ISO 13485, ISO 9001, and ISO 15378 certifications, as well as FDA-registered medical device operations. In 2023, Natech was acquired by STRATEC and now operates as part of the STRATEC Group, extending its reach in IVD and life sciences manufacturing. The business is best characterized as a healthcare-focused manufacturing and engineering partner rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Natech Plastics.